Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 16, 16:00
483.60
-1.5 (-0.31%)
VOLUME 69,816
LIVE
NSE
Aug 16, 15:53
483.25
-1.8 (-0.37%)
VOLUME 708,802
News on Cadila Healthcare
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Zydus Cadila gets USFDA nod for blood pressure drug

12.59 pm | 16 Aug 2017 |  Source: PTI

The approval by the US Food and Drug Administration (USFDA) for diltiazem hydrochloride (Tiadylt ER) extended release capsules is for multiple strengt...

Buy Cadila Healthcare; target of Rs 565: IDBI Capital

3.30 pm | 14 Aug 2017 |  Source: Moneycontrol.com

IDBI Capital is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 565 in its research report dated 12 Aug...

Zydus settles patent case over Aptalis' drug Canasa

2.53 pm | 14 Aug 2017 |  Source: PTI

As a result of the settlement, the company's "US subsidiary, Zydus Pharmaceuticals (USA) Inc, will be able to market its generic version of Canasa...

Cadila Healthcare profits drop 65% to Rs 138.4 crore in Q1

12.10 pm | 11 Aug 2017 |  Source: Moneycontrol.com

Cadila Healthcare, part of Zydus Cadila group on Friday posted 65 percent decline in net profit in the first quarter ended June as pricing pressure in...

Cadila Healthcare: Outcome of board meeting

11.52 am | 11 Aug 2017 |  Source: Moneycontrol.com

Unaudited Financial Results for the quarter ended on June 30, 2017....

Zydus Cadila gets USFDA nod to market hypertension drug

1.05 pm | 09 Aug 2017 |  Source: PTI

The company has received final approval from the US Food and Drug Administration (USFDA) to market Diltiazem Hydrochloride extended release capsules U...

Zydus receives tentative approval from USFDA for Abacavir and Lamivudine tablets USP

12.28 pm | 08 Aug 2017 |  Source: Moneycontrol.com

Zydus Cadila has received the tentative approval from the USFDA to market Abacavir and Lamivudine tablets USP, 600mg/ 300mg....

Zydus receives final approval from USFDA for Memantine Hydrochloride Extended-Release Capsules

8.59 am | 07 Aug 2017 |  Source: Moneycontrol.com

Zydus has received final approval from the US FDA for Memantine Hydrochloride Extended-Release Capsules in strength of 7, 14, 21 and 28 mg. for the tr...

Sell Cadila Healthcare, Just Dial; buy Hindustan Zinc: Ashwani Gujral 

12.06 pm | 04 Aug 2017 |  Source: CNBC-TV18

According to Ashwani Gujral of ashwanigujral.com, one can sell Cadila Healthcare and Just Dial and buy Hindustan Zinc....

Cadila Healthcare rises 2% as Temozolomide and Nadolol drugs receive USFDA nod

12.42 pm | 01 Aug 2017 |  Source: Moneycontrol.com

Temozolomide is a chemotherapy drug used in the management of brain tumors and Nadolol is used for hypertension (high blood pressure) and angina pecto...

Zydus receives final approval from USFDA for Temozolomide Capsules

12.07 pm | 01 Aug 2017 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA to market for Temozolomide Capsules....

Zydus receives final approval from USFDA for Mesalamine tablets

1.13 pm | 25 Jul 2017 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA for Mesalamine delayed-release tablets in the strength of 800 mg....

Cadila Healthcare gains 3% on USFDA nod for Mesalamine that treats ulcerative colitis 

12.56 pm | 25 Jul 2017 |  Source: Moneycontrol.com

Analysts feel Cadila could make USD 75 million per annum from the Asacol HD sales with 95 percent margin....

Cadila rises 4% on Mesalamine launch in US, FDA nod for Tranexamic & Pitavastatin

11.39 am | 19 Jul 2017 |  Source: Moneycontrol.com

The USFDA also gave final approval to market Tranexamic acid injection, 1000mg/10 ml (100 mg/ml) single dose vial....

Zydus launches Mesalamine Delayed Release tablets in US market

9.21 am | 19 Jul 2017 |  Source: Moneycontrol.com

Zydus Cadila has commercially launched its Mesalamine Delayed Release Tablets USP, 1.2 g in the US market....

Buy Cadila Healthcare, Indian Bank, ACC, Syngene; sell Petronet LNG: Mitessh Thakkar 

11.00 am | 17 Jul 2017 |  Source: CNBC-TV18

According to Mitessh Thakkar of mitesshthakkar.com, one may buy Cadila Healthcare, Indian Bank, ACC and Syngene and can sell Petronet LNG....

8 hot stock picks from Anand Rathi Share and Stock Brokers

10.21 am | 17 Jul 2017 |  Source: Moneycontrol.com

8 stocks are the radar of Anand Rathi Share and Stock Brokers...

Buy Cadila Health, JSW Steel, Kajaria Ceramics, HUL; sell BHEL: Sudarshan Sukhani 

10.17 am | 17 Jul 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com suggests buying Cadila Healthcare, JSW Steel, Kajaria Ceramics and Hindustan Unilever and advises selling Bharat ...

Cadila Healthcare's board meeting on August 11, 2017

8.46 am | 17 Jul 2017 |  Source: Moneycontrol.com

We hereby inform that the meeting of the Board of Directors of the Company will be held on Friday, the August 11, 2017 to consider, inter alia, approv...

Pharma weekly wrap: stocks continue rally as positive news flow in

3.27 pm | 15 Jul 2017 |  Source: Moneycontrol.com

The BSE Healthcare index gained 2 percent in the past week, while the benchmark Sensex increased 1.62 percent...

1 2 3 4 5
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.